Founded by Flagship Pioneering, Cellarity is designing medicines against the cell asopposed to a single molecular target.
ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come.
Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome editing as well as vast experience in Immune shielding.
Siduma Therapeutics, founded by innovator Dr. Craig Crews, is leveraging extensive heterobifunctional molecule expertise to build a new, disruptive therapeutic platform targeting disease causing proteins.
Headquartered in Boston, Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases.